81 Results for "

HCV replicon

" in MedChemExpress (MCE) Product Catalog:
Products (81)

81 Results for "HCV replicon" in MCE Product Catalog:

48
48 Publications Verification
Art. -Nr.: HY-10466
CAS. Nr.: 1009119-64-5
Reinheit:  98.68%
Synonyms: BMS-790052; EBP 883
Target:  

HCV

Forschungsgebiete:  

Infection

Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 µM and 3.27 µM, respectively .
loading...
    loading...
48
48 Publications Verification
Art. -Nr.: HY-10465
CAS. Nr.: 1009119-65-6
Reinheit:  99.68%
Synonyms: BMS-790052 dihydrochloride; EBP 883 dihydrochloride
Target:  

HCV

Forschungsgebiete:  

Infection

Daclatasvir dihydrochloride (BMS-790052 dihydrochloride) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir dihydrochloride is also an organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 μM and 3.27 μM, respectively .
loading...
    loading...
34
34 Cited Publications
Art. -Nr.: HY-10237
CAS. Nr.: 394730-60-0
Reinheit:  98.52%
Synonyms: EBP 520; SCH 503034
Target:  

HCV Protease HCV SARS-CoV

Forschungsgebiete:  

Infection

Boceprevir (EBP 520) is a potent, highly selective, orally bioavailable HCV NS3 protease inhibitor with a Ki of 14 nM in both enzyme assay and an EC90 of 350 nM in cell-based replicon assay . Boceprevir inhibits SARS-CoV-2 3CL pro activity .
loading...
    loading...
29
29 Cited Publications
Art. -Nr.: HY-W063968
CAS. Nr.: 691868-88-9
Synonyms: CDM-3008; RO4948191
Target:  

IFNAR JAK STAT HCV HBV

Forschungsgebiete:  

Infection

RO8191 (CDM-3008), an imidazonaphthyridine compound, is an orally active and potent interferon (IFN) receptor agonist. RO8191 directly binds to IFNα/β receptor 2 (IFNAR2) and activates IFN-stimulated genes (ISGs) expression and JAK/STAT phosphorylation. RO8191 shows antiviral activity against both HCV and EMCV with an IC50 of 200 nM for HCV replicon . RO8191 is a cccDNA modulator (CDM) through interferon-like activity and has anti-HBV activity .
loading...
    loading...
15
15 Cited Publications
Art. -Nr.: HY-13998
CAS. Nr.: 1132935-63-7
Reinheit:  98.17%
Synonyms: ABT-333
Target:  

HCV DNA/RNA Synthesis

Forschungsgebiete:  

Infection

Dasabuvir (ABT-333) is a nonnucleoside hepatitis C virus (HCV) polymerase inhibitor. Dasabuvir inhibits RNA-dependent RNA polymerase encoded by the HCV NS5B gene. Dasabuvir inhibits genotype 1a (strain H77) and 1b (strain Con1) replicons, with EC50 values of 7.7 and 1.8 nM, respectively .
loading...
    loading...
12
12 Cited Publications
Art. -Nr.: HY-N6798
CAS. Nr.: 35891-70-4
Synonyms: Thermozymocidin; ISP-I
Myriocin (Thermozymocidin), a fungal metabolite could be isolated from Myriococcum albomyces, Isaria sinclairi and Mycelia sterilia, is a potent inhibitor of serine-palmitoyl-transferase (SPT) and a key enzyme in de novo synthesis of sphingolipids. Myriocin suppresses replication of both the subgenomic HCV-1b replicon and the JFH-1 strain of genotype 2a infectious HCV, with an IC50 of 3.5 μg/mL for inhibiting HCV infection .
loading...
    loading...
11
11 Cited Publications
Art. -Nr.: HY-135867E
Reinheit:  97.09%
NHC-triphosphate tetraammonium is an active phosphorylated intracellular metabolite of β-d-N4-Hydroxycytidine (NHC) (HY-125033) as a triphosphate form . NHC-triphosphate tetraammonium is a weak alternative substrate for the viral polymerase and can be incorporated into HCV replicon RNA .
loading...
    loading...
10
10 Cited Publications
Art. -Nr.: HY-12530
CAS. Nr.: 1377049-84-7
Reinheit:  99.57%
Synonyms: GS-5816
Target:  

HCV SARS-CoV

Forschungsgebiete:  

Infection Inflammation/Immunology Cancer

Velpatasvir (VEL, GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CL pro inhibitor with an IC50 of 2.16 μM .
loading...
    loading...
4
4 Cited Publications
Art. -Nr.: HY-10118
CAS. Nr.: 877130-28-4
Reinheit:  ≥99.0%
Target:  

HCV DNA/RNA Synthesis

Forschungsgebiete:  

Infection

Filibuvir is an orally active, selective non-nucleoside inhibitor of the HCV nonstructural 5B protein (NS5B) RNA-dependent RNA polymerase (RdRp). Filibuvir binds noncovalently in the thumb II allosteric pocket of NS5B. Filibuvir inhibits genotype 1a and 1b replicons with EC50s of 59 nM for both isoforms, respectively . Filibuvir preferentially inhibits elongative RNA synthesis and potently decreases viral RNA accumulation .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-125371
CAS. Nr.: 15397-12-3
Reinheit:  99.50%
Target:  

HCV

Forschungsgebiete:  

Infection Inflammation/Immunology

2'-C-Methyladenosine is an inhibitor of hepatitis C virus (HCV) replication. 2'-C-Methyladenosine inhibits HCV replicon and NS5B-catalyzed RNA synthesis with IC50 values of 0.3μM and 1.9 μM, respectively. 2'-C-Methyladenosine also potently inhibits LRV1 in Leishmania guyanensis (Lgy) and Leishmania braziliensis .
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-15236
CAS. Nr.: 863329-66-2
Reinheit:  99.89%
Synonyms: RO 2433; GS-331007
Target:  

HCV

Forschungsgebiete:  

Infection

PSI-6206 (RO 2433) is the deaminated derivative of PSI-6130, which is a potent and selective inhibitor of HCV NS5B polymerase. PSI-6206 low potently inhibits HCV replicon with EC90 of >100 μM.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-10444
CAS. Nr.: 478182-28-4
Reinheit:  99.60%
Synonyms: 4'-Azidocytidine
Target:  

HCV DNA/RNA Synthesis

Forschungsgebiete:  

Infection

R-1479 (4'-Azidocytidine), a nucleoside analogue, is a specific inhibitor of RNA-dependent RNA polymerase (RdRp) of HCV. R-1479 inhibits HCV replication in the HCV subgenomic replicon system (IC50=1.28 μM) . R-1479 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
3
3 Cited Publications
Art. -Nr.: HY-13465
CAS. Nr.: 1200133-34-1
Reinheit:  98.38%
Target:  

HCV Virus Protease

Forschungsgebiete:  

Infection

VCH-916 is a thiophene derivative and non-nucleoside inhibitor of HCV NS5B polymerase. VCH-916 binds to Thumb Site II. VCH-916 can be used for the research of hepatitis c virus (hcv) infection .
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-101662
CAS. Nr.: 1353900-92-1
Reinheit:  99.94%
Synonyms: ABT-530
Target:  

HCV

Forschungsgebiete:  

Infection

Pibrentasvir is a novel and pan-genotypic hepatitis C virus (HCV) NS5A inhibitor with EC50s ranging from 1.4 to 5.0 pM against HCV replicons containing NS5A from genotypes 1 to 6.
loading...
    loading...
2
2 Cited Publications
Art. -Nr.: HY-75800
CAS. Nr.: 1026785-55-6
Synonyms: VX-222
Target:  

DNA/RNA Synthesis HCV

Forschungsgebiete:  

Infection

Lomibuvir (VX-222), a selective, non-nucleoside polymerase inhibitor, targets thumb pocket 2 of the HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC50 of 5.2 nM. Lomibuvir preferentially inhibits elongative RNA synthesis rather than de novo-initiated RNA synthesis .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-10468
CAS. Nr.: 20724-73-6
Reinheit:  99.90%
Synonyms: 2'-C-Methylcytidine
Target:  

HCV

Forschungsgebiete:  

Infection

NM107 (2'-C-Methylcytidine) is an nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, the EC50 of NM107 in the wild-type replicon cells is 1.85 μM .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-109035
CAS. Nr.: 942123-43-5
Reinheit:  99.87%
Synonyms: SB9200; GS-9992
Target:  

HCV HBV

Forschungsgebiete:  

Infection

Inarigivir soproxil (SB9200) is an agonist of innate immunity and shows potent antiviral activity against resistant HCV variants, with EC50s of 2.2 and 1.0 μM for HCV 1a/1b in cells of genotype 1 HCV replicon systems. Inarigivir soproxil, an orally bioavailable proagent of SB 9000, has broad-spectrum antiviral activity against RNA viruses including HCV, norovirus, respiratory syncytial virus and influenza and HBV .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-15005S1
CAS. Nr.: 1868135-06-1
Reinheit:  98.35%
Synonyms: PSI-7977-d6; GS-7977-d6
Sofosbuvir-d6 is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-10244
CAS. Nr.: 443642-29-3
Reinheit:  99.81%
Target:  

HCV

Forschungsgebiete:  

Infection

MK-0608 is a potent and orally bioavailable inhibitor of HCV replication in vitro with an EC50 of 0.3 μM (EC90=1.3 μM) in the subgenomic-replicon assay .
loading...
    loading...
1
1 Cited Publications
Art. -Nr.: HY-16784
CAS. Nr.: 1312547-19-5
Synonyms: IDX719; IDX18719
Target:  

HCV HCV Protease

Forschungsgebiete:  

Infection

Samatasvir (IDX71) is a potent, orally active NS5A inhibitor of HCV replication. Samatasvir is effective and selective against infectious HCV and replicons, with EC50s falling within a tight range of 2 to 24 pM in genotype 1 through 5 replicons .
loading...
    loading...